Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04474470
Title A Study to Evaluate NT219 Alone and in Combination With ERBITUX (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors TyrNovo Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR

Facility Status City State Zip Country Details
California Cancer Associates for Research and Excellence Encinitas California 92024 United States Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
UCSD Moores Cancer Center San Diego California 92037 United States Details
MedStar Georgetown University Hospital Washington, D.C. District of Columbia 20007 United States Details
The University of Chicago and Biological Sciences Chicago Illinois 60637 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73117 United States Details
Hadassah University Medical Center Jerusalem Israel Details
Rabin Medical Center Petah tikva Israel Details
Sourasky Medical Center Tel Aviv Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field